Gufic BioScience

64
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
440.55
4.95 (1.14%)
BSENSE

Sep 21, 12:33 PM

BSE+NSE Vol: 49.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
No of Months
12
12
12
Operating Income
944.00
819.00
806.00
Less :Inter divisional transfers
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
Net Sales
944.00
819.00
806.00
Expenditure (Ex Depriciation)
Stock Adjustments
-68.00
-24.00
0.00
Raw Materials Consumed
490.00
399.00
389.00
Power & Fuel Cost
32.00
18.00
17.00
Employee Cost
151.00
127.00
109.00
Operating Expenses
45.00
29.00
28.00
General and Administration Expenses
-1.00
-1.00
-1.00
Selling and Distribution Expenses
43.00
47.00
40.00
Cost of Software developments
0.00
0.00
0.00
Miscellaneous Expenses
10.00
12.00
8.00
Expenses Capitalised
0.00
0.00
0.00
Total Expenditure
792.00
683.00
659.00
Operating Profit (PBDIT) excl Other Income
151.00
136.00
147.00
Other Income
2.00
3.00
2.00
Operating Profit (PBDIT)
153.00
139.00
149.00
Interest
36.00
24.00
16.00
Profit before Depriciation and Tax
117.00
115.00
132.00
Depreciation
30.00
21.00
17.00
Profit Before Taxation & Exceptional Items
86.00
94.00
115.00
Exceptional Income / Expenses
0.00
0.00
0.00
Profit Before Tax
86.00
94.00
115.00
Provision for Tax
22.00
24.00
29.00
Profit After Tax
64.00
69.00
86.00
Extraordinary Items
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
Profit Balance B/F
420.00
352.00
267.00
Profit Available for appropriations
485.00
422.00
353.00
Appropriations
485.00
422.00
353.00
Equity Dividend (%)
10.00%
10.00%
10.00%
Earnings Per Share
6.40
6.95
8.74
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 15.15% vs 1.63% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 11.19% vs -7.60% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 49.32% vs 46.04% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is -7.81% vs -19.14% in Mar 2025

Compare Profit and Loss Results of Gufic BioScience
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
944.00
707.00
237.00
33.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
944.00
707.00
237.00
33.52%
Expenditure (Ex Depriciation)
Stock Adjustments
-68.00
-21.00
-47.00
-223.81%
Raw Materials Consumed
490.00
274.00
216.00
78.83%
Power & Fuel Cost
32.00
18.00
14.00
77.78%
Employee Cost
151.00
141.00
10.00
7.09%
Operating Expenses
45.00
30.00
15.00
50.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
43.00
31.00
12.00
38.71%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
10.00
18.00
-8.00
-44.44%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
792.00
559.00
233.00
41.68%
Operating Profit (PBDIT) excl Other Income
151.00
147.00
4.00
2.72%
Other Income
2.00
25.00
-23.00
-92.00%
Operating Profit (PBDIT)
153.00
173.00
-20.00
-11.56%
Interest
36.00
1.00
35.00
3,500.00%
Profit before Depriciation and Tax
117.00
171.00
-54.00
-31.58%
Depreciation
30.00
21.00
9.00
42.86%
Profit Before Taxation & Exceptional Items
86.00
150.00
-64.00
-42.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
86.00
154.00
-68.00
-44.16%
Provision for Tax
22.00
39.00
-17.00
-43.59%
Profit After Tax
64.00
115.00
-51.00
-44.35%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
420.00
474.00
-54.00
-11.39%
Profit Available for appropriations
485.00
589.00
-104.00
-17.66%
Appropriations
485.00
589.00
-104.00
-17.66%
Equity Dividend (%)
10%
300%
-290.00
Earnings Per Share
6.4
69.64
-63.24
-90.81%
Profit And Loss - Net Sales
Net Sales 944.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 15.15% vs 1.63% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.34 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.19% vs -7.60% in Mar 2025

Profit And Loss - Interest
Interest 36.61 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.32% vs 46.04% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 64.21 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -7.81% vs -19.14% in Mar 2025